Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedApr 16, 2025
DataAggregated Company Financials
Companies5
  • 7D1.6%
  • 3M-21.0%
  • 1Y-32.2%
  • YTD-23.6%

All of the companies in the Biotech industry have been up over the last week, with the industry up 1.6%. In the past year, the industry is down 32%. Earnings are forecast to grow by 3.9% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 16 Apr 2025DKK 125.9bDKK 27.3bDKK 7.7b11.2x16.4x4.6x
Fri, 14 Mar 2025DKK 142.8bDKK 27.3bDKK 7.7b12x18.6x5.2x
Sun, 09 Feb 2025DKK 153.8bDKK 26.0bDKK 4.7b15.5x32.8x5.9x
Tue, 07 Jan 2025DKK 166.1bDKK 26.0bDKK 4.7b17.7x35.4x6.4x
Thu, 05 Dec 2024DKK 165.7bDKK 26.0bDKK 4.7b17.1x35.3x6.4x
Sat, 02 Nov 2024DKK 175.7bDKK 25.5bDKK 5.5b20.9x32.1x6.9x
Mon, 30 Sep 2024DKK 180.2bDKK 25.5bDKK 5.5b22.3x32.9x7.1x
Wed, 28 Aug 2024DKK 201.2bDKK 25.5bDKK 5.5b25.7x36.8x7.9x
Fri, 26 Jul 2024DKK 202.9bDKK 24.8bDKK 5.6b18.5x36x8.2x
Sun, 23 Jun 2024DKK 176.3bDKK 24.8bDKK 5.6b16.7x31.3x7.1x
Tue, 21 May 2024DKK 183.8bDKK 24.8bDKK 5.6b19.1x32.6x7.4x
Thu, 18 Apr 2024DKK 179.9bDKK 23.9bDKK 5.0b18.9x35.7x7.5x
Sat, 16 Mar 2024DKK 190.0bDKK 23.9bDKK 5.0b19.6x37.8x7.9x
Mon, 12 Feb 2024DKK 169.1bDKK 23.3bDKK 4.2b23x40.6x7.3x
Wed, 10 Jan 2024DKK 182.9bDKK 23.3bDKK 4.2b26.2x43.9x7.8x
Fri, 08 Dec 2023DKK 178.9bDKK 23.3bDKK 4.2b26x43x7.7x
Sun, 05 Nov 2023DKK 161.8bDKK 22.0bDKK 4.7b19.2x34.1x7.3x
Tue, 03 Oct 2023DKK 194.6bDKK 22.0bDKK 4.7b22.5x41.1x8.8x
Thu, 31 Aug 2023DKK 202.9bDKK 22.0bDKK 4.7b24x43x9.2x
Sat, 29 Jul 2023DKK 201.6bDKK 19.5bDKK 4.4b35.3x45.8x10.3x
Mon, 26 Jun 2023DKK 203.3bDKK 19.5bDKK 4.4b42.9x46.1x10.4x
Wed, 24 May 2023DKK 221.3bDKK 19.5bDKK 4.4b44.3x50.2x11.3x
Fri, 21 Apr 2023DKK 209.3bDKK 17.9bDKK 3.5b32.8x59.2x11.7x
Sun, 19 Mar 2023DKK 190.4bDKK 17.9bDKK 3.5b29.7x53.7x10.6x
Tue, 14 Feb 2023DKK 206.0bDKK 14.7bDKK 3.3b31.5x63x14x
Thu, 12 Jan 2023DKK 209.4bDKK 14.7bDKK 3.3b32x64x14.2x
Sat, 10 Dec 2022DKK 236.0bDKK 14.7bDKK 3.3b37.1x72.1x16x
Mon, 07 Nov 2022DKK 220.1bDKK 12.4bDKK 1.5b48.8x144.9x17.7x
Wed, 05 Oct 2022DKK 197.4bDKK 12.4bDKK 1.5b43.6x129.9x15.9x
Fri, 02 Sep 2022DKK 191.7bDKK 12.4bDKK 1.5b42.3x128.8x15.4x
Sun, 31 Jul 2022DKK 201.5bDKK 11.1bDKK 130.5m71.3x1544.2x18.2x
Tue, 28 Jun 2022DKK 169.4bDKK 11.1bDKK 130.5m62.6x1298.3x15.3x
Thu, 26 May 2022DKK 157.1bDKK 11.0b-DKK 88,588,000.0058.2x-1773.8x14.2x
Sat, 23 Apr 2022DKK 181.1bDKK 10.7bDKK 622.4m55.2x291x16.9x
Price to Earnings Ratio

291x


Total Market Cap: DKK 181.1bTotal Earnings: DKK 622.4mTotal Revenue: DKK 10.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 85.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 16.4x which is lower than its 3-year average PE of 85.5x.
  • The 3-year average PS ratio of 10.2x is higher than the industry's current PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 131% per year over the last three years.
  • Revenues for these companies have grown 37% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market1.51%
Healthcare-1.33%
Biotech1.60%
Biotech1.60%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.29k1.9%
+DKK 1.6b		-37.2%PE10.5x
BAVA Bavarian NordicDKK 151.002.1%
+DKK 241.2m		-0.8%PE11.9x
ZEAL Zealand PharmaDKK 445.000.4%
+DKK 134.3m		-26.4%PS501.7x
BIOPOR BioPortoDKK 1.517.3%
+DKK 44.0m		19.3%PS17.9x
STRAP Strategic PartnersDKK 1.09k21.7%
+DKK 8.1m		3.8%PB2.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOPOR

DKK 1.51

BioPorto

7D

7.3%

1Y

19.3%

BAVA

DKK 151.00

Bavarian Nordic

7D

2.1%

1Y

-0.8%

GMAB

DKK 1,293.00

Genmab

7D

1.9%

1Y

-37.2%

ZEAL

DKK 445.00

Zealand Pharma

7D

0.4%

1Y

-26.4%

Most Shareholders Will Probably Find That The CEO Compensation For Zealand Pharma A/S (CPH:ZEAL) Is Reasonable

Mar 21
Most Shareholders Will Probably Find That The CEO Compensation For Zealand Pharma A/S (CPH:ZEAL) Is Reasonable

STRAP

DKK 1,090.00

Strategic Partners

7D

21.7%

1Y

3.8%